Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Investigators at Tianjin Medical University zero in on cancer gene therapy
February 17th, 2009
New investigation results, 'Changes of the alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis,' are detailed in a study published in Pathobiology. "We attempted to reveal the changes of the human telomerase reverse transcriptase (hTERT) alternative splicing pattern in gastric carcinogenesis. Three alternative splicing sites (alpha, beta, gamma) were selected and designed PCR primer," scientists in Tianjin, People's Republic of China report. "The expression of 8 hTERT alternative splicing variants (ASVs) in normal gastric mucosa, precancerous lesions and gastric cancer were detected by seminested RT-PCR. The...
Source: Cancer Weekly (2009-02-17)
|
